Tomas Ganz is a co-founder of Intrinsic LifeSciences. He holds a Ph.D. in Applied Physics from the California Institute of Technology and an M.D. from UCLA. Tom trained in Internal Medicine and Pulmonary Critical Care at UCLA, and has been on the faculty of UCLA since 1983, now as a Professor of Medicine and Pathology.
He participated in the founding of Intrabiotics, and has consulted for major biotechnology and pharmaceutical companies including Xenon, Ceragenix, Isis, Fibrogen and Hoffman-La Roche. He has studied the biology of host defense peptides since 1983, discovered the iron regulatory peptide hepcidin in the 1990s, and has made major contributions to the revolution in iron biology and the understanding of iron-related disease that has taken place during the last decade. In 2005, Tom received the Marcel Simon Award from the International BioIron Society (IBIS) for “Contributions to the knowledge of iron metabolism and its disorders”. He has published more than 200 peer-reviewed articles.
Tomas Ganz’s Selected Publications:
For the full list of publications, click here http://www.ncbi.nlm.nih.gov/pubmed?term=Ganz%20T%20AND%20Los%20Angeles